University of Sfax-ko ikertzaileekin lankidetzan egindako argitalpenak (23)

2024

  1. Synthesis and Biological Evaluation of New Benzochromenopyrimidines for the Therapy of Colon and Lung Cancer

    ChemistrySelect, Vol. 9, Núm. 2

2023

  1. Biginelli Reaction Synthesis of Novel Multitarget-Directed Ligands with Ca2+ Channel Blocking Ability, Cholinesterase Inhibition, Antioxidant Capacity, and Nrf2 Activation

    Molecules, Vol. 28, Núm. 1

  2. Design, Synthesis, in Silico and Biological Evaluation of Novel 4-Aminopyrimidine-5-carbonitriles

    ChemistrySelect, Vol. 8, Núm. 31

  3. Exploring the Potential of Sulfonamide-Dihydropyridine Hybrids as Multitargeted Ligands for Alzheimer’s Disease Treatment

    International Journal of Molecular Sciences, Vol. 24, Núm. 11

2022

  1. Benzochromenopyrimidines: Synthesis, Antiproliferative Activity against Colorectal Cancer and Physicochemical Properties

    Molecules, Vol. 27, Núm. 22

2021

  1. Regioselective Synthesis of Novel [1,2,4]Triazolo[1,5-a]pyridine Derivatives

    ChemistrySelect, Vol. 6, Núm. 5, pp. 945-950

  2. Synthesis and Biological Assessment of PyrimidoTacrines as Promising Agents for Alzheimer's Disease Therapy

    ChemistrySelect, Vol. 6, Núm. 37, pp. 9975-9980

  3. Synthesis and Fluorescence of (E)-3-Aryl-2-(5-aryl-4H-1,2,4-triazol-3-yl) Acrylonitriles

    ChemistrySelect, Vol. 6, Núm. 25, pp. 6360-6364

  4. Tacrines as Therapeutic Agents for Alzheimer's Disease. V. Recent Developments

    Chemical Record, Vol. 21, Núm. 1, pp. 162-174

2020

  1. Triazolopyridopyrimidine: A new scaffold for dual-target small molecules for Alzheimer's disease therapy

    Molecules, Vol. 25, Núm. 14

2019

  1. Multi-target 1,4-dihydropyridines showing calcium channel blockade and antioxidant capacity for Alzheimer's disease therapy

    Bioorganic Chemistry, Vol. 91

  2. New Dual Small Molecules for Alzheimer's Disease Therapy Combining Histamine H3 Receptor (H3R) Antagonism and Calcium Channels Blockade with Additional Cholinesterase Inhibition

    Journal of Medicinal Chemistry, Vol. 62, Núm. 24, pp. 11416-11422

  3. Synthesis and biological assessment of KojoTacrines as new agents for Alzheimer’s disease therapy

    Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 34, Núm. 1, pp. 163-170

  4. Synthesis of (±)-cis-1-Aryl-3-oxo-2,3-dihydro-1H-benzo[f]chromene-2-carbonitriles and (±)-trans-4-Aryl-2-oxo-3,4-dihydro-2H-benzo[h]chromene-3-carbonitriles

    ChemistrySelect, Vol. 4, Núm. 44, pp. 12902-12905

2018

  1. Synthesis, Biological Assessment and Molecular Modeling of Racemic QuinoPyranoTacrines for Alzheimer's Disease Therapy

    ChemistrySelect, Vol. 3, Núm. 2, pp. 461-466

2017

  1. Synthesis and biological assessment of racemic benzochromenopyrimidinetriones as promising agents for Alzheimer's disease therapy

    Future Medicinal Chemistry, Vol. 9, Núm. 8, pp. 715-721

  2. Tetrahydropyranodiquinolin-8-amines as new, non hepatotoxic, antioxidant, and acetylcholinesterase inhibitors for Alzheimer's disease therapy

    European Journal of Medicinal Chemistry, Vol. 126, pp. 576-589

2016

  1. Synthesis and Biological Assessment of Racemic Benzochromenopyrimidinimines as Antioxidant, Cholinesterase, and Aβ1−42Aggregation Inhibitors for Alzheimer's Disease Therapy

    ChemMedChem, pp. 1318-1327

  2. Synthesis and biological evaluation of benzochromenopyrimidinones as cholinesterase inhibitors and potent antioxidant, non-hepatotoxic agents for Alzheimer's disease

    Molecules, Vol. 21, Núm. 5

2014

  1. Isoxazolotacrines as non-toxic and selective butyrylcholinesterase inhibitors for Alzheimer's disease

    Future Medicinal Chemistry, Vol. 6, Núm. 17, pp. 1883-1891